Literature DB >> 28874056

Ceruloplasmin, a Potential Therapeutic Agent for Alzheimer's Disease.

Ya-Shuo Zhao1,2, Li-Hong Zhang1, Pan-Pan Yu1, Yu-Jing Gou1, Jing Zhao1, Lin-Hao You1, Zhan-You Wang3, Xin Zheng1, Liang-Jun Yan4, Peng Yu1, Yan-Zhong Chang1,5.   

Abstract

AIMS: Ceruloplasmin (CP), a ferrous oxidase enzyme, plays an important role in regulating iron metabolism and redox reactions. Previous studies showed that CP deficiency contributes to Parkinson's disease by increasing iron accumulation and oxidative stress in the substantia nigra. However, the role of CP in Alzheimer's disease (AD) is unclear. We hypothesized that the lack of CP gene expression would affect the pathogenesis and damage of AD by promoting abnormal iron levels and oxidative stress.
RESULTS: AD mouse models were induced in CP knockout mouse either by injection of Aβ25-35 into the lateral ventricle of the brain or transgenic APP expression. CP levels were decreased significantly in the hippocampus of AD patients, as well as Aβ-CP+/+ and APP-CP+/+ mice. Compared to control AD mice, CP gene deletion increased memory impairment and iron accumulation, which could be associated with elevated reactive oxygen species (ROS) levels and lead to cell apoptosis mediated through the Bcl-2/Bax and Erk/p38 signaling pathways in Aβ-CP-/- and APP-CP-/- mice. In contrast, the restoration of CP expression to CP-/- mice through injection of an exogenous expression plasmid into the brain ventricle alleviated Aβ-induced neuronal damage in the hippocampus. INNOVATION: CP alterations in iron contents were mediated through DMT1(-IRE) and changes in ROS levels, which in turn attenuated the progression of AD through the Erk/p38 and Bcl-2/Bax signaling pathways.
CONCLUSION: Our results show a protective role of CP in AD and suggest that regulating CP expression in the hippocampus may provide a new neuroprotective strategy for AD. Antioxid. Redox Signal. 28, 1323-1337.

Entities:  

Keywords:  Alzheimer's disease; apoptosis; ceruloplasmin; iron; oxidative stress; β-amyloid

Mesh:

Substances:

Year:  2017        PMID: 28874056     DOI: 10.1089/ars.2016.6883

Source DB:  PubMed          Journal:  Antioxid Redox Signal        ISSN: 1523-0864            Impact factor:   8.401


  9 in total

1.  Ceruloplasmin Deficiency Impaired Brain Iron Metabolism and Behavior in Mice.

Authors:  Lijing Niu; Yi Zhou; Li Lu; Aixia Su; Xiaoqiang Guo
Journal:  Cell Biochem Biophys       Date:  2022-02-11       Impact factor: 2.989

2.  Overdosing on iron: Elevated iron and degenerative brain disorders.

Authors:  Santosh R D'Mello; Mark C Kindy
Journal:  Exp Biol Med (Maywood)       Date:  2020-09-02

3.  Active compounds of herbs ameliorate impaired cognition in APP/PS1 mouse model of Alzheimer's disease.

Authors:  WenJun Yu; ShengJun An; TieMei Shao; HongJun Xu; HongXu Chen; JunDa Ning; YongJie Zhou; XiQing Chai
Journal:  Aging (Albany NY)       Date:  2019-12-09       Impact factor: 5.682

4.  Circulating proteomic signature for detection of biomarkers in bladder cancer patients.

Authors:  Taoufik Nedjadi; Hicham Benabdelkamal; Nada Albarakati; Afshan Masood; Ahmed Al-Sayyad; Assim A Alfadda; Ibrahim O Alanazi; Adel Al-Ammari; Jaudah Al-Maghrabi
Journal:  Sci Rep       Date:  2020-07-03       Impact factor: 4.379

5.  Involvement of Hepcidin in Cognitive Damage Induced by Chronic Intermittent Hypoxia in Mice.

Authors:  Ya-Shuo Zhao; Miao Tan; Ji-Xian Song; Ji-Ren An; Xin-Yue Yang; Wen-Ya Li; Ya-Jing Guo; En-Sheng Ji
Journal:  Oxid Med Cell Longev       Date:  2021-08-04       Impact factor: 6.543

Review 6.  Iron Dyshomeostasis and Ferroptosis: A New Alzheimer's Disease Hypothesis?

Authors:  Feixue Wang; Jiandong Wang; Ying Shen; Hao Li; Wolf-Dieter Rausch; Xiaobo Huang
Journal:  Front Aging Neurosci       Date:  2022-03-22       Impact factor: 5.750

Review 7.  Effect of metal ions on Alzheimer's disease.

Authors:  Fan Liu; Zhuo Zhang; Lin Zhang; Ruo-Ni Meng; Jia Gao; Ming Jin; Ming Li; Xiao-Peng Wang
Journal:  Brain Behav       Date:  2022-02-24       Impact factor: 2.708

Review 8.  Can the administration of platelet lysates to the brain help treat neurological disorders?

Authors:  Ouada Nebie; Luc Buée; David Blum; Thierry Burnouf
Journal:  Cell Mol Life Sci       Date:  2022-06-24       Impact factor: 9.207

9.  Lower Expression of Ndfip1 Is Associated With Alzheimer Disease Pathogenesis Through Decreasing DMT1 Degradation and Increasing Iron Influx.

Authors:  Juan Tian; Wei Zheng; Xin-Lu Li; Yuan-Hong Cui; Zhan-You Wang
Journal:  Front Aging Neurosci       Date:  2018-06-08       Impact factor: 5.750

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.